Medium materiality6/10
West Pharmaceutical price target raised to $390 from $350 at KeyBanc
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
WST received an analyst target update from KeyBanc.
- Target $390 vs price $365; upgrade by KeyBanc
Key facts
- 01
Target: $390
- 02
Posted price: $365
- 03
Analyst firm: KeyBanc
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.